Evidence of sustained benefits of pimavanserin for dementia-related psychosis

Researchers have published evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis.

from Healthy Aging News -- ScienceDaily https://ift.tt/3izXsHf